Almost certainly one of the first issues to be discussed at the first meeting of the biosimilar working group including the two key industry associations will be the status of so-called 'clones'. …
Latest Video
New Stories
-
The genesis of the policy that continues to shape PBS discussions
January 17, 2019 - - Latest News -
Takeda rings the bell in New York
January 17, 2019 - - Latest News -
Novo Nordisk's Michala Fischer-Hansen returning to Denmark
January 17, 2019 - - Latest News -
CHF: End cost-offset rule
January 17, 2019 - - Latest News -
Fundraising underway in the race for #PharmaCup2019
January 16, 2019 - - Latest News -
Transition of 6CPA program administration underway
January 16, 2019 - - Latest News -
New drug discovery institute for Melbourne
January 16, 2019 - - Latest News